IBS responds to a combination of dietary changes, targeted medications, and behavioral therapies, though which mix works best depends on your dominant symptoms and subtype. A low-FODMAP diet has the most consistent dietary evidence, but it is far from the only option. Peppermint oil, specific prescription drugs, low-dose antidepressants, and even cognitive behavioral therapy all have solid trial data behind them. The challenge with IBS is less about finding something that works and more about matching the right treatments to the right person.
The Low-FODMAP Diet
FODMAPs are short-chain carbohydrates that ferment quickly in the gut, drawing in water and producing gas. They include fructose, lactose, sugar alcohols like sorbitol, and certain fibers found in wheat, onions, garlic, beans, and many fruits. When researchers compared a low-FODMAP diet to habitual eating in a network meta-analysis, the low-FODMAP approach ranked first for global symptom improvement, outperforming all other dietary interventions studied.1PubMed. Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis A separate meta-analysis found it reduced IBS severity by a moderate-to-large degree compared to control diets.2PubMed Central. Efficacy of a low-FODMAP diet in adult irritable bowel syndrome: a systematic review and meta-analysis Across studies, up to about 86% of patients report improvement in overall symptoms including pain, bloating, and altered bowel habits.3PubMed Central. Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date
The diet is not meant to be permanent. It works in three phases: a strict elimination lasting a few weeks, a structured reintroduction where you test individual FODMAP groups one at a time, and a long-term personalized phase where you eat as broadly as possible while avoiding only your specific triggers. One concern has been whether long-term restriction harms gut bacteria, since FODMAPs feed beneficial microbes like Bifidobacteria. Short-term studies did find a drop in Bifidobacteria during the elimination phase, but whether that persists after reintroduction is still unclear.4PubMed Central. Effects of a low FODMAP diet on the colonic microbiome in irritable bowel syndrome: a systematic review with meta-analysis Longer-term follow-up studies found no lasting change in overall gut microbiota composition, though some short-chain fatty acids did decrease.5Current Developments in Nutrition. The Long-Term Effects of a Low–Fermentable Oligosaccharides, Disaccharides, Monosaccharides, and Polyols Diet for Irritable Bowel Syndrome Management The practical takeaway: follow the reintroduction phase seriously rather than staying on strict elimination indefinitely.
Simpler Dietary Approaches That Also Work
Low-FODMAP gets the most press, but it is also restrictive, time-consuming, and harder to follow when eating out. A randomized trial comparing low-FODMAP, a gluten-free diet, and traditional dietary advice (eat regular meals, reduce caffeine and alcohol, limit fatty and spicy foods, watch portion sizes) found no statistically significant difference in the proportion of people who hit a meaningful symptom improvement threshold. About 42% responded to traditional advice, 55% to low-FODMAP, and 58% to gluten-free, and those differences were not large enough to be statistically reliable.6PubMed. Efficacy and Acceptability of Dietary Therapies in Non-Constipated Irritable Bowel Syndrome: A Randomized Trial of Traditional Dietary Advice, the Low FODMAP Diet, and the Gluten-Free Diet Participants found traditional advice cheaper, easier when eating out, and simpler to fit into daily life. This suggests that if the low-FODMAP diet feels overwhelming, starting with basic dietary hygiene is a reasonable first step.
Which Fiber Helps and Which Makes Things Worse
Advice to “eat more fiber” has been standard for decades, but the type of fiber matters enormously. Short-chain, rapidly fermentable fibers like wheat bran and oligosaccharides produce gas quickly, which can worsen bloating and pain. By contrast, long-chain, soluble fibers like psyllium ferment more slowly, producing less gas and acting as a gentle stool regulator.7PubMed Central. Dietary fiber in irritable bowel syndrome (Review)
A three-arm randomized trial comparing psyllium, bran, and placebo confirmed this distinction in practice. Psyllium beat placebo during both the first and second months, with roughly 57-59% of patients responding compared to 35-41% on placebo. After three months, symptom severity in the psyllium group dropped by 90 points compared to 49 in the placebo group. Bran performed poorly by comparison, and dropout was highest in the bran group because symptoms actually worsened for many of those patients.8The BMJ. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial If you have been told to eat more fiber and it made you feel worse, the culprit was likely the kind of fiber, not fiber itself. Psyllium husk, taken with plenty of water, is the form best supported by evidence.
Peppermint Oil
Peppermint oil in enteric-coated capsules is one of the most effective over-the-counter options for IBS, and it has been strangely under-discussed relative to its evidence base. It works as a smooth muscle relaxant, blocking calcium channels in the intestinal wall to reduce spasms.9PubMed Central. Review article: The physiologic effects and safety of Peppermint Oil and its efficacy in irritable bowel syndrome and other functional disorders Multiple meta-analyses have found it more effective than placebo for reducing abdominal pain, with one reporting a number needed to treat of about four, meaning you would need to give peppermint oil to four patients for one additional person to get pain relief compared to placebo.10PubMed Central. The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data An older but influential systematic review found an even more favorable number needed to treat of about 2.5 across peppermint oil trials.11BMJ. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis
The enteric coating is important. Without it, peppermint oil can dissolve in the stomach and cause heartburn. Side effects are generally mild, mostly consisting of a minty aftertaste or cool sensation during bowel movements. Peppermint oil is particularly useful for pain-predominant symptoms and is safe to combine with other treatments.
Prescription Medications by Subtype
IBS is typically classified by bowel pattern: IBS with diarrhea (IBS-D), IBS with constipation (IBS-C), or mixed. Medications are tailored accordingly, and the evidence for each subtype differs.
For IBS With Diarrhea
Rifaximin, a non-absorbable antibiotic that stays in the gut, is one of the better-studied drugs for IBS-D. In two large placebo-controlled trials, about 41% of patients on rifaximin achieved adequate relief of global IBS symptoms, compared with roughly 32% on placebo. It also improved bloating, pain, and stool consistency.12PubMed. Rifaximin therapy for patients with irritable bowel syndrome without constipation Interestingly, its benefit seems to come from something beyond simply killing bacteria. Rifaximin causes only modest shifts in gut microbiota composition, leading researchers to suspect it also affects intestinal permeability and inflammatory signaling.13PubMed Central. Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review One advantage is that a short two-week course can produce durable improvement, and the treatment can be repeated if symptoms return.14PubMed Central. Rifaximin in irritable bowel syndrome: rationale, evidence and clinical use
For IBS With Constipation
Several secretagogues, drugs that draw fluid into the intestinal lumen to soften stool and speed transit, have been tested. A network meta-analysis found that linaclotide, lubiprostone, plecanatide, and tenapanor all outperformed placebo. Linaclotide ranked first across multiple endpoints, including the FDA’s recommended composite measure, abdominal pain, and spontaneous bowel movements.15PubMed. Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis Its main side effect is diarrhea, which can sometimes be managed by taking a lower dose. If you have IBS-C and dietary changes alone are not enough, linaclotide is the drug with the strongest evidence to ask your doctor about.
Low-Dose Antidepressants for Gut Pain
The name trips people up, so it is worth saying clearly: when doctors prescribe a low-dose antidepressant for IBS, they are not treating depression. They are targeting the nerve signaling between the brain and the gut. IBS involves disruptions in the gut-brain axis, with structural and functional changes that alter how the nervous system processes pain signals from the intestines.16PubMed Central. Uncovering the pathophysiology of irritable bowel syndrome by exploring the gut-brain axis: a narrative review Low-dose tricyclic antidepressants (TCAs) like amitriptyline work by modifying how the central nervous system processes pain, reducing visceral hypersensitivity, which is the amplified perception of normal gut activity that many IBS patients experience.17Evidence-Based GI. Low-dose Tricyclic Antidepressants for Irritable Bowel Syndrome: Definitive Evidence of Benefit from ATLANTIS
A meta-analysis of antidepressants for IBS found a roughly 34% improvement over placebo for both TCAs and SSRIs. The benefit was consistent across both drug classes, though the evidence was a bit more heterogeneous for SSRIs.18American Journal of Gastroenterology. Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis The doses used for IBS are typically a fraction of what is prescribed for depression. Side effects at these low doses tend to be mild, things like dry mouth or drowsiness, but they are worth discussing with your prescriber. TCAs are generally preferred for IBS-D because they slow the gut, while SSRIs may be more appropriate for IBS-C.
Cognitive Behavioral Therapy and Hypnotherapy
Psychological therapies for IBS are not about convincing you the symptoms are “in your head.” They work on the same gut-brain communication pathway that antidepressants target, but from the brain’s side of the equation. A 2024 network meta-analysis of brain-gut behavioral treatments found that self-guided or minimal-contact cognitive behavioral therapy (CBT) and face-to-face gut-directed hypnotherapy both reduced abdominal pain compared to control conditions.19PubMed. Effect of Brain-Gut Behavioral Treatments on Abdominal Pain in Irritable Bowel Syndrome: Systematic Review and Network Meta-Analysis Face-to-face multicomponent behavioral therapy also performed well.
The practical appeal of CBT for IBS is that self-guided versions, often delivered through apps or workbooks with minimal therapist contact, show similar benefit to intensive face-to-face sessions. That makes it accessible to people who cannot find or afford a specialized therapist. Gut-directed hypnotherapy is more niche, typically requiring a trained practitioner, but produces some of the most durable results seen in IBS research, with benefits sometimes lasting years after treatment ends. These therapies work best alongside dietary and pharmacological approaches, not as replacements.
Exercise
Structured physical activity improves IBS symptoms, though the evidence base is smaller than for dietary or drug treatments. A randomized controlled trial found that patients assigned to increase their physical activity saw a meaningful drop in symptom severity scores compared to a control group that maintained their usual activity level. The control group was also more likely to experience worsening symptoms over the study period.20American Journal of Gastroenterology. Physical Activity Improves Symptoms in Irritable Bowel Syndrome: A Randomized Controlled Trial A Cochrane review pooling five studies also found symptom improvement, though it rated the evidence as very uncertain due to small sample sizes and methodological limitations.21PubMed Central. Physical activity for treatment of irritable bowel syndrome
Beyond direct gut effects, exercise reduces stress and improves mood, both of which feed into the gut-brain axis that drives IBS symptoms. There is also emerging evidence that regular aerobic exercise improves the diversity and composition of gut bacteria.22PubMed Central. Effects of Physical Exercise on the Microbiota in Irritable Bowel Syndrome You do not need intense training. Moderate-intensity aerobic activity like brisk walking, cycling, or swimming appears sufficient. The key seems to be consistency rather than intensity.
Probiotics
Probiotics are the treatment people most often try on their own, and the evidence is genuinely mixed. Not all probiotics are created equal, and many products on store shelves have never been tested specifically for IBS. A systematic review using multi-criteria analysis found that formulations based on Lactobacillus rhamnosus and Lactobacillus acidophilus showed the highest efficacy, particularly for quality of life, bloating, and abdominal pain.23PubMed Central. Evaluating the Efficacy of Probiotics in IBS Treatment Using a Systematic Review of Clinical Trials and Multi-Criteria Decision Analysis But the overall field is plagued by small studies, short durations, and enormous variation in strains and doses. If you try a probiotic, commit to a specific well-studied strain for at least four weeks before deciding whether it is helping.
Sleep Disruption and Symptom Flares
Poor sleep does not just accompany IBS; it appears to actively worsen symptoms the next day. A study tracking sleep and symptoms over time in IBS patients found that more frequent waking episodes during the night predicted higher abdominal pain ratings and greater overall gastrointestinal distress the following day. The relationship held across multiple measurement tools. Interestingly, sleep disturbance was linked specifically to pain and distress rather than to bowel pattern changes like diarrhea or constipation.24PubMed Central. Effects of Disturbed Sleep on Gastrointestinal and Somatic Pain Symptoms in IBS This means that improving sleep quality, whether through better habits, treating an underlying sleep disorder, or managing nighttime anxiety, is a legitimate and often overlooked piece of IBS management.
When IBS Starts After an Infection
A significant minority of IBS cases begin after an episode of acute gastroenteritis, a form known as post-infectious IBS. The mechanisms likely involve lingering low-grade inflammation, changes in intestinal permeability, and shifts in gut flora that persist long after the infection has cleared.25PubMed Central. Post-infectious irritable bowel syndrome One study following a water-borne viral gastroenteritis outbreak found that 40 patients developed new IBS within a year, compared to just 3 in a control group, representing more than a tenfold increase in odds.26American Journal of Gastroenterology. Incidence of Post-Infectious Irritable Bowel Syndrome and Functional Intestinal Disorders Following a Water-Borne Viral Gastroenteritis Outbreak
The good news is that post-infectious IBS tends to gradually improve over time, and most patients eventually see their symptoms resolve. Risk factors include the severity of the initial illness (especially vomiting) and pre-existing psychological conditions like anxiety.27PubMed. Postinfectious irritable bowel syndrome after a food-borne outbreak of acute gastroenteritis attributed to a viral pathogen If your IBS started suddenly after a bad stomach bug, this context may be worth sharing with your doctor, as it can affect how aggressively to treat and how optimistic to be about the long-term outlook.
Ruling Out Celiac Disease
About 4% of people who meet the diagnostic criteria for IBS actually have undiagnosed celiac disease, which is roughly four times higher than the odds in people without IBS symptoms.28JAMA Internal Medicine. Yield of Diagnostic Tests for Celiac Disease in Individuals With Symptoms Suggestive of Irritable Bowel Syndrome: Systematic Review and Meta-analysis Since celiac disease has a specific treatment (strict, lifelong gluten avoidance) and carries real consequences if left undiagnosed (nutritional deficiencies, increased risk of certain cancers), most guidelines recommend that anyone diagnosed with IBS, particularly the diarrhea-predominant subtype, get tested for celiac disease with a blood test before settling into IBS management. If the test comes back negative, you can pursue IBS-specific treatments with more confidence.
Fecal Microbiota Transplantation
Fecal microbiota transplantation (FMT), where a healthy donor’s stool is introduced into the patient’s gut, has generated considerable interest as a potential IBS treatment. The results so far are genuinely mixed. Of seven randomized controlled trials reviewed, four found positive effects on IBS symptoms, while three found none at all.29PubMed Central. Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century The inconsistency appears to stem from major differences in how these trials were run, including the donor selection process, the dose of transplanted material, and whether it was delivered by colonoscopy, nasal tube, or capsule.
A more recent meta-analysis found that FMT may reduce IBS symptoms at 12 weeks, but the evidence remained uncertain in the primary analysis. Single-dose FMT appeared more promising than repeated capsule-based dosing.30PubMed. Fecal Microbiota Transplantation for Symptom Improvement in Patients With Irritable Bowel Syndrome: Systematic Review and Meta-Analysis of Randomized Controlled Trials An earlier meta-analysis actually found that multi-dose capsule FMT reduced the likelihood of improvement, suggesting that more is not necessarily better and that the delivery method may be critical.31PubMed Central. Efficacy of Fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis FMT for IBS is not ready for routine clinical use, but the science is still developing, and better-standardized protocols may eventually show clearer results.
The Placebo Puzzle
One reason IBS is difficult to study is that placebo responses are unusually high. More than a quarter of IBS patients in drug trials improve on placebo alone, and some analyses put the figure closer to 37.5%.32PubMed. The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis33Journal of Neurogastroenterology and Motility. Placebo Effect in Clinical Trial Design for Irritable Bowel Syndrome This does not mean the condition is imaginary; it means the brain’s expectations and the therapeutic context (regular appointments, attention from a provider, hope) genuinely modulate gut function. It also means that any treatment showing only a modest edge over placebo, like some of the drugs discussed above, can still be producing real physiological change on top of a strong context effect. For patients, the takeaway is that the relationship with your healthcare provider and your confidence in the treatment plan likely matter more than in many other conditions.
IBS in Children and Adolescents
IBS is not just an adult condition. Children and teenagers get it too, though the treatment evidence is thinner and the approaches are somewhat different. Italian and European pediatric guidelines strongly suggest dietary approaches, psychologically directed therapies, and in select cases gut-brain neuromodulators under specialist supervision.34PubMed Central. Italian guidelines for the management of irritable bowel syndrome in children and adolescents However, the evidence for specific dietary interventions like the low-FODMAP diet in children is much weaker than in adults. Some data support psyllium fibers and certain probiotics, but the overall picture is that dietary manipulation has not been as reliably helpful in pediatric populations.35PubMed Central. A therapeutic guide on pediatric irritable bowel syndrome and functional abdominal pain-not otherwise specified
Joint European and North American pediatric gastroenterology guidelines have evaluated 86 randomized trials and generated 25 graded recommendations for treating IBS and functional abdominal pain in children aged 4-18.36PubMed Central. ESPGHAN/NASPGHAN guidelines for treatment of irritable bowel syndrome and functional abdominal pain-not otherwise specified in children aged 4-18 years In practice, many pediatric gastroenterologists lean heavily on reassurance, stress management, and psychological interventions before reaching for medications. Restrictive diets in growing children carry nutritional risks that do not apply to adults, making the risk-benefit calculation different. If your child has IBS, working with a pediatric specialist rather than extrapolating from adult treatment protocols is particularly important.